Literature DB >> 36152126

Acupuncture for the management of dry eye disease.

Julia Prinz1, Nicola Maffulli2,3,4, Matthias Fuest1, Peter Walter1, Frank Hildebrand5, Filippo Migliorini6.   

Abstract

The effectiveness of using acupuncture for dry eye disease (DED) is controversial. Thus, this systematic review investigated the effectiveness and feasibility of using acupuncture for DED in accordance with the 2020 PRISMA statement. The outcomes of interests were (1) to evaluate the efficacy of acupuncture in improving the ocular surface disease index (OSDI), Schirmer I test score, and tear breakup time from baseline to the last follow-up; (2) to determine possible complications of using acupuncture; and (3) to investigate the superiority of acupuncture over other commonly used treatments for DED. Data from 394 patients were collected. Results showed that acupuncture significantly prolonged the tear breakup time (P < 0.0001), significantly increased the Schirmer I test score (P < 0.0001), and significantly reduced the OSDI (P < 0.0001) from baseline to the last follow-up. Compared with the control group, the acupuncture group had significantly greater Schirmer I test score (P < 0.0001), significantly longer tear breakup time (P = 0.0004), and significantly lower OSDI (P = 0.002). These results suggest that acupuncture is effective and feasible in improving symptoms and signs of DED. No severe adverse effects of acupuncture were observed.
© 2022. Higher Education Press.

Entities:  

Keywords:  acupuncture; dry eye disease; xerophthalmus

Year:  2022        PMID: 36152126     DOI: 10.1007/s11684-022-0923-4

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   9.927


  43 in total

1.  Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.

Authors:  Hyung Keun Lee; Ik Hee Ryu; Kyoung Yul Seo; SoonWon Hong; Hyung Chang Kim; Eung Kweon Kim
Journal:  Ophthalmology       Date:  2005-12-19       Impact factor: 12.079

Review 2.  Advances in understanding and managing dry eye disease.

Authors:  Michael A Lemp
Journal:  Am J Ophthalmol       Date:  2008-07-02       Impact factor: 5.258

Review 3.  Management of dry eye disease.

Authors:  Michael A Lemp
Journal:  Am J Manag Care       Date:  2008-04       Impact factor: 2.229

Review 4.  TFOS DEWS II Definition and Classification Report.

Authors:  Jennifer P Craig; Kelly K Nichols; Esen K Akpek; Barbara Caffery; Harminder S Dua; Choun-Ki Joo; Zuguo Liu; J Daniel Nelson; Jason J Nichols; Kazuo Tsubota; Fiona Stapleton
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 5.  TFOS DEWS II Report Executive Summary.

Authors:  Jennifer P Craig; J Daniel Nelson; Dimitri T Azar; Carlos Belmonte; Anthony J Bron; Sunil K Chauhan; Cintia S de Paiva; José A P Gomes; Katherine M Hammitt; Lyndon Jones; Jason J Nichols; Kelly K Nichols; Gary D Novack; Fiona J Stapleton; Mark D P Willcox; James S Wolffsohn; David A Sullivan
Journal:  Ocul Surf       Date:  2017-08-08       Impact factor: 5.033

6.  Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.

Authors:  Laura E Downie; Sueko M Ng; Kristina B Lindsley; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-12-18

Review 7.  Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis.

Authors:  Xiao Qing Zhou; Rui Li Wei
Journal:  Cornea       Date:  2014-07       Impact factor: 2.651

8.  Understanding the true burden of dry eye disease.

Authors:  Anat Galor; Roy C Levitt; Elizabeth R Felix; Constantine D Sarantopoulos
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

9.  Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review.

Authors:  Ann-Margret Ervin; Andrew Law; Andrew D Pucker
Journal:  Br J Ophthalmol       Date:  2018-10-18       Impact factor: 4.638

Review 10.  A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome.

Authors:  Yun-Jung Yang; Won-Young Lee; Young-Jin Kim; Yeon-Pyo Hong
Journal:  Int J Environ Res Public Health       Date:  2021-03-01       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.